Related Experiment Video
Updated: Dec 14, 2025
03:05
Author Spotlight: Advancing Early Detection and Treatment of Gastrointestinal Tumors
Published on: February 16, 2024
1.4K
Gastric EBV-positive mucocutaneous ulcer: A rare pathological entity
Azza Gabsi1, Yosr Zenzri1, Ghada Sahraoui2
1Medical Oncology Department Faculty of Medicine of Tunis El Manar University Salah Azaiez Institute Tunis Tunisia.
Clinical Case Reports
|July 23, 2020
Summary
Gastric Epstein-Barr virus-positive mucin-depleted lesions (EBVMCU) are very rare. Diagnosis requires pathology examination and immunochemistry, and physician awareness is key for proper management.
Area of Science:
- Gastroenterology
- Oncology
- Pathology
Background:
- Epstein-Barr virus-positive mucin-depleted lesions (EBVMCU) represent a rare entity.
- Gastric involvement of EBVMCU is exceptionally uncommon, posing diagnostic challenges.
Observation:
- This study highlights the rarity of EBVMCU in the gastric location.
- Diagnostic challenges associated with this rare gastric malignancy are noted.
Findings:
- Pathology examination and immunohistochemistry are indispensable for accurate diagnosis.
- Definitive diagnostic criteria for gastric EBVMCU are established through these methods.
Implications:
- Increased physician awareness of gastric EBVMCU is essential for timely diagnosis.
- Prompt and accurate diagnosis facilitates appropriate patient management and treatment strategies.
- Recognizing this rare entity improves understanding of EBV-associated gastric cancers.
Related Concept Videos
01:30Peptic Ulcer Disease I: Introduction
638
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
638
01:28Peptic Ulcer Disease II: Pathophysiology
1.7K
Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
1.7K
01:25Mucosal Barrier of the Stomach
1.7K
The gastric glands contain parietal cells that secrete hydrochloric acid (HCl) for digestion. The cells secrete HCl because it is highly corrosive and essential for breaking down food. To achieve this, they secrete hydrogen and chloride ions into the lumen of the gastric glands, which combine to form HCl.
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
Within parietal cells, carbonic acid is first formed through the reaction of water and carbon dioxide. The dissociation of carbonic acid releases bicarbonate and hydrogen ions. The bicarbonate...
1.7K
01:21Barrett Esophagus-II: Clinical Manifestations and Management
589
Individuals with Barrett's esophagus are often asymptomatic, but they may experience symptoms commonly associated with GERD, such as heartburn and acid regurgitation. Additional symptoms can include difficulty swallowing, chest pain, unintentional weight loss, blood in the stool (which may appear black, tarry, or bloody), and episodes of vomiting.
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
To diagnose Barrett's esophagus, healthcare providers often recommend an endoscopy for those showing symptoms of acid reflux. The procedure...
589
01:28Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
413
Peptic ulcer disease (PUD) presents with diverse symptoms depending on the location and severity of the ulcer. Clinical manifestations of peptic ulcer include dull pain and a burning sensation in the mid-epigastric region.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
413
01:24Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
1.0K
Peptic ulcer disease, commonly called PUD, represents a multifaceted condition characterized by disruptions in the lining of the gastrointestinal (GI) tract. Central to the protection of the gastrointestinal lining is the mucosal-bicarbonate barrier. This physiological defense mechanism is a formidable shield against the corrosive effects of gastric acid and pepsin secretion in the stomach. Its role is pivotal in maintaining the structural integrity of the stomach's inner lining.
1.0K